Navigation Links
Inverness Medical Innovations Announces Third Quarter 2008 Results
Date:10/29/2008

excluding such charges and income from income or loss allows

investors and management to evaluate and compare the Company's

operating results from continuing operations from period to period

in a meaningful and consistent manner. Due to the frequency of

their occurrence in its business, the Company does not adjust net

income or loss for the costs associated with litigation, including

payments made or received through settlements. It should be noted

that "net income or loss on an adjusted cash basis" is not a

standard financial measurement under accounting principles generally

accepted in the United States of America ("GAAP") and should not be

considered as an alternative to net income or loss or cash flow from

operating activities, as a measure of liquidity or as an indicator

of operating performance or any measure of performance derived in

accordance with GAAP. In addition, all companies do not calculate

non-GAAP financial measures in the same manner and, accordingly,

"net income or loss on an adjusted cash basis" presented in this

press release may not be comparable to similar measures used by

other companies.

(b) Amortization expense of $60.0 million and $19.9 million in the third

quarter of 2008 and 2007 GAAP results, respectively, including $10.5

million and $7.5 million charged to cost of sales, $1.0 million and

$0.6 million charged to research and development and $48.3 million

and $11.7 million charged to selling, general and administrative, in

the respective quarters, with $0.2 million and $0.1 million charged

through equity earnings of unconsolidated entities, net of tax

during the respective quarters.

( c ) Restructuring charges associated with the decisi
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET October 29, 2008 to Discuss Third Quarter 2008 Results
2. Inverness Medical Innovations to Present at the UBS Global Life Sciences Conference on September 22, 2008
3. Inverness Medical Innovations to Attend the Goldman Sachs Diagnostics Conference on September 18, 2008
4. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
5. Inverness Medical Innovations to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008
6. Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
7. Inverness Medical Innovations to Present at Canaccord Adams 28th Annual Growth Conference on August 12, 2008
8. Inverness Medical Innovations Announces Second Quarter 2008 Results
9. Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008
10. Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008
11. Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... N.C., July 28, 2015  United Therapeutics Corporation (NASDAQ: ... for the second quarter ended June 30, 2015. ... compared to the second quarter of 2014 when ... Ph.D., United Therapeutics, President and Co-Chief Executive Officer. ... an increase in the number of patients being ...
(Date:7/27/2015)... FRANKLIN, Tenn. , July 27, 2015 ... of health care services and one of the ... announced that its parent company and sole stockholder, ... with Medical Properties Trust, Inc. ("MPT") (NYSE: ... million in cash.  The transaction is expected to be ...
(Date:7/27/2015)... Wis. (PRWEB) , ... July 27, 2015 , ... ... and facility identification solutions, today announced a new video: 3 Ways to ... OSHA’s Hazard Communication Standard and the Globally Harmonized System (GHS) by effectively labeling ...
(Date:7/27/2015)... 2015 According to the new Market ... Pre-formulated Media), by Application (Biobanking, Regenerative Medicine, Drug Discovery), by ... , Asia-Pacific , Rest of the ... media market was valued at $247.7 million in 2014, which ... at a CAGR of 18.2% between 2014 and 2019. ...
Breaking Biology Technology:United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 2United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 3United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 4United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 5United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 6United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 7United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 8United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 9United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 10United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 11Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 3Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 4Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 5Brady Releases “3 Roads to GHS Labels” Video 2Global Biopreservation Media Market to be Worth $571.5 Million by 2019 2Global Biopreservation Media Market to be Worth $571.5 Million by 2019 3
... 1 Environmental Tectonics Corporation,s (OTC Bulletin Board: ETCC) ("ETC" ... of a BARA-MED((R)) XD Monoplace Hyperbaric Chamber to ... area. , , Hyperbaric Oxygen Therapy ... patient breathes 100% oxygen while fully enclosed in a specially ...
... China, Sept. 1 /PRNewswire-Asia-FirstCall/ -- China Kangtai Cactus,Biotech ... grower,developer, manufacturer and marketer of a variety of ... has successfully completed the trial,production of cactus-based cigarettes ... quarter in 2009: (i) low nicotine and (ii) ...
... BOSTON, Sept. 1 PAREXEL International Corporation (Nasdaq: ... Robert Baird 2009 Healthcare Conference in New York, NY. James ... be making a formal presentation on PAREXEL at 10:30 a.m. EDT ... live webcast of this presentation will be available under the "Upcoming ...
Cached Biology Technology:Environmental Tectonics Corporation's BioMedical Systems Division Announces the Sale of a Monoplace Hyperbaric Chamber 2Environmental Tectonics Corporation's BioMedical Systems Division Announces the Sale of a Monoplace Hyperbaric Chamber 3Environmental Tectonics Corporation's BioMedical Systems Division Announces the Sale of a Monoplace Hyperbaric Chamber 4China Kangtai Cactus Biotech to Launch Patented Cactus-based Low Tar, Low or Zero Nicotine Cigarettes 2China Kangtai Cactus Biotech to Launch Patented Cactus-based Low Tar, Low or Zero Nicotine Cigarettes 3PAREXEL International to Present at Robert Baird 2009 Healthcare Conference 2
(Date:7/27/2015)... SAN JOSE, Calif. , July 27, 2015 ... leading developer of human interface solutions, today announced ... ClearPad ® touchscreen solution for its stylish ... controller for its proven reliability, low power and ... with a wet finger. Huawei designers also required ...
(Date:7/27/2015)... , July 27, 2015   Zynx ... and experience-based clinical improvement solutions, today announced that ... is now available on Android smartphones and tablets. ... and post-care organizations can use ZynxCarebook to securely ... patient,s condition, streamline care transitions to other care ...
(Date:7/23/2015)... BEDFORD, Mass., July 23, 2015 Aware, Inc. (NASDAQ: ... services, today reported financial results for its second quarter ended ... quarter of 2015 was $4.5 million, a decrease of 33% ...  Net income in the second quarter of 2015 was $0.3 ... million, or $0.04 per diluted share, in the same period ...
Breaking Biology News(10 mins):Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
... found a way to stabilize hemoglobin, the oxygen carrier ... to the development of stable vaccines and affordable artificial ... the polymer poly(acrylic acid) around hemoglobin, protecting it from ... to maintain its biological function and structural integrity. ...
... from the Photosynthetic Systems Division at the U.S. Department ... at Rensselaer Polytechnic Institute are expanding a successful research ... protein, Photosystem II. The high-impact research, led by professor ... as an abundant source of renewable energy. "I ...
... Dec. 3, 2013 (Toronto) - People who carry a high-risk ... in childhood, decades before the illness appears, new research from ... The gene, called SORL1, is one of a number of ... the most common form of the illness. SORL1 carries the ...
Cached Biology News:New method for stabilizing hemoglobin could lead to stable vaccines, artificial blood 2New method for stabilizing hemoglobin could lead to stable vaccines, artificial blood 3Rensselaer researchers to map step-by-step mechanism of photosynthesis 2Rensselaer researchers to map step-by-step mechanism of photosynthesis 3Rensselaer researchers to map step-by-step mechanism of photosynthesis 4Alzheimer's risk gene may begin to affect brains as early as childhood, CAMH research shows 2Alzheimer's risk gene may begin to affect brains as early as childhood, CAMH research shows 3
The Hybrid Hunter Yeast Two-Hybrid System uses the activation of reporter genes to indicate positive protein-protein interactions. Two reporters are used an auxotrophic marker and lacZ....
Mus musculus MARCKS-like protein, mRNA...
Tris-Hepes kit of BG-163 & BG-165 (order number BG-166)...
... The NEW HandyStep electronic from BRAND ... pipetting. It is the only electronic, ... standard syringe tips, including BRAND PD-Tip ... Plus, Fisherbrand Dispenser Tips,and VWRbrand Combi-Syringes. ...
Biology Products: